MYC and myeloid neoplasm: c-MYC is required to maintain the balance between self-renewal and differentiation of hematopoietic stem cells (HSCs); not surprisingly, c-MYC is commonly overexpressed in both solid and hematopoietic malignancies (both lymphoid and myeloid neoplasms).